Drug: insulin Quarter: 2016Q3
Total Records: 528 Number of Pages: 27
DRUGNAME | PT | EventCount |
---|---|---|
INSULIN GLARGINE | Intentional overdose | 2 |
INSULIN GLARGINE | Intentional product misuse | 2 |
INSULIN GLARGINE | Myocardial infarction | 2 |
INSULIN GLARGINE | Normal newborn | 2 |
INSULIN GLARGINE | Parkinsonism | 2 |
INSULIN GLARGINE | Polycystic ovaries | 2 |
INSULIN GLARGINE | Rhabdomyolysis | 2 |
INSULIN GLARGINE | Sinus tachycardia | 2 |
INSULIN GLARGINE | Thrombocytopenia | 2 |
INSULIN GLARGINE | Toxicity to various agents | 2 |
INSULIN GLARGINE | Urinary tract infection | 2 |
INSULIN GLARGINE | Vasogenic cerebral oedema | 2 |
INSULIN GLARGINE | Ventricular extrasystoles | 2 |
INSULIN GLARGINE | Vision blurred | 2 |
INSULIN GLARGINE | Vomiting | 2 |
Insulin Human | Administration site necrosis | 2 |
Insulin Human | Confusional state | 2 |
Insulin Human | Diabetic retinopathy | 2 |
Insulin Human | Drug ineffective | 2 |
Insulin Human | Fibromyalgia | 2 |
Total Records: 528 Number of Pages: 27